Abstract
Germ line deleterious mutations of BRCA1 gene are not the unique factor that could inactivate BRCA1 protein which leads to familial breast cancer onset with distant metastases’ occurrence. The present research explores the role that could be assigned to BRCA1 SNPs to inactivate BRCA1 protein and therefore to the occurrence of familial breast cancer with an increased risk of distant metastases’ occurrence. The presence or the absence of BRCA1 protein was first analyzed by applying the immunohistochemistry technique to the tumors with sporadic and familial breast cancer. Then, a case–control study was conducted including 40 patients with familial breast cancer, 46 ones with sporadic breast cancer and 34 healthy controls based on the genotyping of nine BRCA1 SNPs (c.442.58delT, c.2082C>T, c.2311T>C, c.2612C>T, c.3113A>G, c.3119G>A, c.3548A>G, c.4308T>C and 4837A>G) via direct sequencing. Finally, the functional role that could be assigned to these SNPs was focused upon. miRbase site was used as a bioinformatics tool to predict potential micro-RNAs (miRs) targeting SNPs that are associated with familial breast cancer according to the results of this research. These predicted miRs were confirmed by Q-PCR analysis and correlated with BRCA1 protein expression among patients along with potential distant metastases. Clinical outcome showed that distant metastasis concerned 45 % of familial breast cancer patients and 19.5 % with sporadic breast cancer. Analysis of BRCA1 protein expression revealed a negative staining among 46.6 % of familial breast cancer patients and only 16.6 % within sporadic breast cancer ones. The association of four variants was identified within BRCA1 gene (c.442.58 delT, c.2311T>C, c.2612C>T and c.4308T>C) to familial breast cancer across their wild genotypes. miR-1179 was selected as potential miR that targets the region of BRCA1 mRNA containing the c.2311T>C variant within the TT genotype. The expression of miR-1179 was significantly associated with familial breast cancer patients without BRCA1 deleterious mutations compared to those with sporadic breast cancer according to TT genotype along with BRCA1 negative staining and according to the occurrence of distant metastases. Combination between TT genotype of c.2311T>C and miR-1179 over-expression could generate a lack of BRCA1 protein leading to a high risk of familial breast cancer with distant metastases.
Similar content being viewed by others
Abbreviations
- FBC:
-
Familial breast cancer
- FFPE:
-
Formalin-fixed, paraffin-embedded
- HC:
-
Healthy controls
- IHC:
-
Immunohistochemistry
- miR:
-
micro-RNA
- Q-PCR:
-
Quantitative real-time polymerase chain reaction
- SBC:
-
Sporadic breast cancer
- SNP:
-
Simple nucleotide polymorphism
References
Saika K, Sobue T. Cancer statistics in the world. Gan To Kagaku Ryoho. 2013;40(13):2475–80.
Charef-Hamza S, et al. Loss of heterozygosity at the BRCA1 locus in Tunisian women with sporadic breast cancer. Cancer Lett. 2005;224(2):185–91.
Guaragnella N, et al. The expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2. FEMS Yeast Res. 2013;111(10):548–62.
Albiges L, et al. Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases. Ann Oncol. 2005;16(11):1846–7.
Egawa C, et al. Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics. Jpn J Cancer Res. 2001;92(6):624–30.
Wu J, Lu LY, Yu X. The role of BRCA1 in DNA damage response. Protein Cell. 2010;1(2):117–23.
Troudi W, et al. Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia. J Hum Genet. 2007;52(11):915–20.
Im KM, et al. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet. 2011;130(5):685–99.
Cao W, et al. BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer. Anat Rec (Hoboken). 2013;296(2):273–8.
Troudi W, et al. Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer. Cancer Biomark. 2008;4(1):11–8.
Chang S, et al. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med. 2011;17(10):1275–82.
Folini M, et al. miR-21: an oncomir on strike in prostate cancer. Mol Cancer. 2010;9:12.
He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522–31.
Moskwa P, et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell. 2011;41(2):210–20.
Griffiths-Jones S, et al. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008;36(Database issue):D154–8.
Olive V, et al. A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. Elife. 2013;2:e00822.
Filipponi D, et al. Wip1 controls global heterochromatin silencing via atm/BRCA1-dependent dna methylation. Cancer Cell. 2013;24(4):528–41.
Di LJ, et al. Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat Struct Mol Biol. 2010;17(12):1406–13.
McMullin RP, et al. A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. Breast Cancer Res. 2014;16(2):R25.
Bouhaha R, et al. Study of TNFalpha-308G/A and IL6-174G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population. Clin Biochem. 2010;43(6):549–52.
Bouhaha R, et al. TCF7L2 is associated with type 2 diabetes in nonobese individuals from Tunisia. Pathol Biol (Paris). 2010;58(6):426–9.
Binns C, Low WY, Lee MK. Breast cancer: an increasing public health problem in the Asia pacific region. Asia Pac J Public Health. 2013;25(5):364–7.
Subramanian S, et al. MicroRNA expression signature of human sarcomas. Oncogene. 2008;27(14):2015–26.
Lin M, et al. MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol Rep. 2011;25(3):739–47.
Acknowledgments
The authors would like to thank all those who have contributed to the realization of this work in Salah Azaiz Institute of Tunis, Laboratory of Genetic Immunology and Human Pathology, Laboratory of Genetics and Molecular Diagnostic “LOM” in Clermont-Ferrand and in Laboratory of Molecular screening in breast cancer in Montreal for their technical assistance.
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Wafa Troudi and Nejla Stambouli have equally contributed this work.
Rights and permissions
About this article
Cite this article
Medimegh, I., Troudi, W., Stambouli, N. et al. Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases’ occurrence. Med Oncol 31, 255 (2014). https://doi.org/10.1007/s12032-014-0255-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-014-0255-6